Jamjoom Pharma’s profits increased to 168.2 million riyals in the first quarter of 2026

Jamjoom Pharmaceutical Factory Company’s profits increased "Jamjoom Pharma" In the first quarter of 2026, by 7%, to 168.2 million riyals, compared to 157 million riyals in the same quarter of last year.

The company said in a statement on its website "Saudi Arabia trading"Net profit increased at a faster growth rate than revenues, as a result of improved operating leverage, effective cost control, and appropriate product and customer mix. This led to a slight expansion in the net profit margin to reach 34.9% during the quarter.

The company’s net profit increased by 147.1% during the current quarter compared to the previous quarter, driven by higher sales, improved gross margins, and increased efficiency in absorbing operating expenses.

• For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter